Dr. Kio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 High Park Ave
Goshen, IN 46526Phone+1 574-364-2888Fax+1 574-364-2480
Education & Training
- Medical University of South CarolinaFellowship, Hematology and Medical Oncology, 2002 - 2005
- Cook County Health and Hospitals SystemResidency, Internal Medicine, 1999 - 2002
- University of Benin Faculty of MedicineClass of 1995
Certifications & Licensure
- IL State Medical License 1999 - 2026
- OH State Medical License 2004 - 2026
- IN State Medical License 2009 - 2025
- SC State Medical License 2002 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer Start of enrollment: 2013 Feb 01
- Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC
- A Trial Assessing Chemo Mouthpiece Device With Best Supportive Care for Symptoms of Chemotherapy-Induced Oral Mucositis Start of enrollment: 2020 Aug 31
Publications & Presentations
PubMed
- 102 citationsTherapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I-inhibiting Antibody-Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab Govitecan.Jhanelle E. Gray, Rebecca S. Heist, Alexander Starodub, D. Ross Camidge, Ebenezer A. Kio
Clinical Cancer Research. 2017-10-01 - 86 citationsA phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non–small cell lung cancer: Hoosier cancer ...Greg Andrew Durm, Salma K. Jabbour, Sandra Althouse, Ziyue Liu, Ahad Ali Sadiq
Cancer. 2020-10-01 - 64 citationsRandomized, Placebo-Controlled, Phase II Study of Veliparib in Combination with Carboplatin and Paclitaxel for Advanced/Metastatic Non–Small Cell Lung CancerSuresh S. Ramalingam, Normand Blais, Julien Mazieres, Martin Reck, C. Michael Jones
Clinical Cancer Research. 2017-04-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: